A Modified Polydopamine Nanoparticle Loaded with Melatonin for Synergistic ROS Scavenging and Anti‐Inflammatory Effects in the Treatment of Dry Eye Disease
Source abstract
Abstract
Abstract Dry eye disease (DED) is a multifaceted ocular surface disorder that significantly impacts patients’ daily lives and imposes a substantial economic burden on society. Oxidative stress, induced by the overproduction of reactive oxygen species (ROS), is a critical factor perpetuating the inflammatory cycle in DED. Effectively scavenging ROS is essential to impede the progression of DED. In this study, boronophenylalanine‐ containing polydopamine (PDA‐PBA) nanoparticles are developed loaded with melatonin (MT), which are blended with poly(vinyl alcohol) (PVA) to create eye drops PVA/ PDA‐PBA@MT (PPP@MT). In vitro and in vivo studies demonstrate that PPP@MT exhibits dual functionalities in reducing ROS production and downregulating inflammatory pathways, thereby preserving mitochondrial integrity and further inhibiting programmed cell death. Following PPP@MT treatment, tear secretion, corneal structure, and the number of goblet cells are markedly restored in a mouse model of dry eye, indicating the therapeutic efficacy of this agent. Collectively, PPP@MT, characterized by minimal side effects and favorable bioavailability, offers promising therapeutic insights for the management of DED and other ROS‐mediated disorders.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Ocular Surface and Contact Lens · Corneal Surgery and Treatments · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Ophthalmology Zhongshan Ophthalmic Center Guangdong Provincial Key Laboratory of Ophthalmology Visual Science Sun Yat‐sen University Guangzhou 510060 China
Beijing Tongren Eye Center Beijing Tongren Hospital Capital Medical University Beijing Key Laboratory of Ophthalmology & Visual Sciences Beijing 100730 China
Funding
Natural Science Foundation of Guangdong Province · National Natural Science Foundation of China
References (56)
Show source-provided references
1. 10.1016/j.jtos.2017.05.00810.1016/j.jtos.2017.05.008 ↗
2. 10.1016/j.ajo.2019.01.02610.1016/j.ajo.2019.01.026 ↗
3. 10.1016/j.jtos.2017.05.01110.1016/j.jtos.2017.05.011 ↗
4. 10.1016/j.jtos.2017.05.00610.1016/j.jtos.2017.05.006 ↗
5. 10.1167/iovs.17-2340210.1167/iovs.17-23402 ↗
6. 10.1111/aos.1352610.1111/aos.13526 ↗
7. 10.1039/D4NH00171K10.1039/D4NH00171K ↗
8. 10.1021/acsnano.3c1151410.1021/acsnano.3c11514 ↗
9. 10.1021/acsnano.3c0886910.1021/acsnano.3c08869 ↗
10. 10.1002/adfm.20230756910.1002/adfm.202307569 ↗
11. 10.1186/s12951-024-02499-010.1186/s12951-024-02499-0 ↗
12. 10.1016/j.smaim.2023.01.00410.1016/j.smaim.2023.01.004 ↗
13. 10.1002/adma.20180536810.1002/adma.201805368 ↗
14. 10.1155/2013/32912110.1155/2013/329121 ↗
15. 10.1042/bj330017510.1042/bj3300175 ↗
16. 10.1002/adfm.20210180410.1002/adfm.202101804 ↗
17. 10.1093/rb/rbac07010.1093/rb/rbac070 ↗
18. 10.1007/s11426-018-9392-610.1007/s11426-018-9392-6 ↗
19. 10.1039/C8NR00838H10.1039/C8NR00838H ↗
20. 10.1126/science.114724110.1126/science.1147241 ↗
21. 10.1016/j.actbio.2023.02.02610.1016/j.actbio.2023.02.026 ↗
22. 10.1016/j.bioadv.2024.21379210.1016/j.bioadv.2024.213792 ↗
23. 10.1021/acsbiomaterials.0c0170510.1021/acsbiomaterials.0c01705 ↗
24. 10.1016/j.biomaterials.2022.12138710.1016/j.biomaterials.2022.121387 ↗
25. 10.1002/adma.20210843010.1002/adma.202108430 ↗
26. 10.1016/j.bioactmat.2023.02.02310.1016/j.bioactmat.2023.02.023 ↗
27. 10.1021/acsmacrolett.6b0083310.1021/acsmacrolett.6b00833 ↗
28. 10.1002/adma.20221039210.1002/adma.202210392 ↗
29. 10.1021/acsnano.1c1104010.1021/acsnano.1c11040 ↗
30. 10.1007/s11426-019-9699-310.1007/s11426-019-9699-3 ↗
31. 10.1002/adfm.20200437710.1002/adfm.202004377 ↗
32. 10.1186/s12974-022-02477-z10.1186/s12974-022-02477-z ↗
33. 10.1002/jcp.3026910.1002/jcp.30269 ↗
34. 10.1016/j.exer.2021.10849110.1016/j.exer.2021.108491 ↗
35. 10.1038/s12276-024-01269-010.1038/s12276-024-01269-0 ↗
36. Wang W. P. T. T. · Adv. Funct. Mater. · 2023 · 13
37. 10.3389/fchem.2021.72712310.3389/fchem.2021.727123 ↗
38. 10.1021/cr400407a10.1021/cr400407a ↗
39. 10.1002/adfm.20120115610.1002/adfm.201201156 ↗
40. 10.1039/D0CC06557A10.1039/D0CC06557A ↗
41. 10.1016/j.biomaterials.2023.12243510.1016/j.biomaterials.2023.122435 ↗
42. 10.1002/pat.586310.1002/pat.5863 ↗
43. 10.1038/sj.eye.670016910.1038/sj.eye.6700169 ↗
44. 10.1002/adfm.20221414510.1002/adfm.202214145 ↗
45. 10.7150/thno.1443110.7150/thno.14431 ↗
46. 10.1021/acsami.3c0648310.1021/acsami.3c06483 ↗
47. 10.3390/antiox1304042210.3390/antiox13040422 ↗
48. 10.1101/cshperspect.a01255910.1101/cshperspect.a012559 ↗
49. 10.1016/j.scitotenv.2019.13636310.1016/j.scitotenv.2019.136363 ↗
50. 10.1167/iovs.63.10.310.1167/iovs.63.10.3 ↗
51. 10.1167/iovs.64.3.3410.1167/iovs.64.3.34 ↗
52. 10.1016/j.bbadis.2016.11.01010.1016/j.bbadis.2016.11.010 ↗
53. 10.1016/j.preteyeres.2010.03.00110.1016/j.preteyeres.2010.03.001 ↗
54. 10.1038/s41598-021-01503-z10.1038/s41598-021-01503-z ↗
55. 10.1002/advs.20230863510.1002/advs.202308635 ↗
56. 10.1016/j.jtos.2019.11.00610.1016/j.jtos.2019.11.006 ↗